AKERO THERAPEUTICS INC filings

SEC filings by AKERO THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G2022-02-04WELLINGTON MANAGEMENT GROUP LLPAkero Therapeutics, Inc.1,876,8115.4%EDGAR
SC 13G2021-12-13Point72 Asset Management, L.P.Akero Therapeutics, Inc.1,747,8495.0%EDGAR
SC 13G2021-06-30Skorpios TrustAkero Therapeutics, Inc.2,346,2986.7%EDGAR
SC 13D/A2021-06-29ATP Life Science Ventures, L.P.Akero Therapeutics, Inc.37,5550.1%EDGAR
SC 13D/A2021-05-07venBio Global Strategic Fund II L.P.Akero Therapeutics, Inc.2,315,8936.6%EDGAR
SC 13G/A2021-02-16Versant Venture Capital VI, L.P.Akero Therapeutics, Inc.777,7272.2%EDGAR
SC 13G/A2021-02-16Atlas Venture Fund XI, L.P.Akero Therapeutics, Inc.2,206,4126.4%EDGAR
SC 13G2021-02-16Redmile Group, LLCAkero Therapeutics, Inc.2,322,5576.7%EDGAR
SC 13G/A2021-02-11JANUS HENDERSON GROUP PLCAkero Therapeutics, Inc.3,493,41910.1%EDGAR
SC 13G2021-02-11ALKEON CAPITAL MANAGEMENT LLCAkero Therapeutics, Inc.2,287,6306.6%EDGAR
SC 13G/A2021-02-05AMGEN INCAkero Therapeutics, Inc.1,508,375-EDGAR
SC 13G/A2020-09-10JANUS HENDERSON GROUP PLCAkero Therapeutics, Inc.3,507,22810.1%EDGAR
SC 13D/A2020-09-09venBio Global Strategic Fund II L.P.Akero Therapeutics, Inc.2,668,7177.7%EDGAR
SC 13D/A2020-07-14Apple Tree Partners IV, L.P.Akero Therapeutics, Inc.5,830,20317.2%EDGAR
SC 13D/A2020-07-08venBio Global Strategic Fund, L.P.Akero Therapeutics, Inc.3,033,55210.6%EDGAR
SC 13G/A2020-02-14Versant Venture Capital VI, L.P.Akero Therapeutics, Inc.3,656,58512.8%EDGAR
SC 13G2020-02-14JANUS HENDERSON GROUP PLCAkero Therapeutics, Inc.2,409,5338.4%EDGAR
SC 13G2020-02-13Atlas Venture Fund XI, L.P.Akero Therapeutics, Inc.2,706,4129.5%EDGAR
SC 13G2020-02-10AMGEN INCAkero Therapeutics, Inc.1,905,698-EDGAR
SC 13D/A2020-01-15venBio Global Strategic Fund II L.P.Akero Therapeutics, Inc.3,322,13811.6%EDGAR